SCHEMBL23671510

SCHEMBL23671510

O=[N+]([O-])c1ccc(C2(CO)CCOCC2)c(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.46
▸ GPR35 Q9HC97 2/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ TP53 P04637 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ GAA P10253 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ERN1 O75460 1/20 0.37
▸ AKR1C3 P42330 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KCNJ1 P48048 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16423195 0.79 L3MBTL1 (0.47) CTSBSMN1; SMN2ALDH1A1TSHRHTT
SCHEMBL23671577 0.78 L3MBTL1 (0.48) CTSBGPR35SMN1; SMN2ALDH1A1TP53
SCHEMBL6612675 0.74 ALDH1A1 (0.44) GPR35SMN1; SMN2ALDH1A1TP53HPGD
SCHEMBL2655331 0.68 HSP90AA1 (0.59) ALDH1A1L3MBTL1HSP90AA1
SCHEMBL3913610 0.67 L3MBTL1 (0.44) SMN1; SMN2ALDH1A1HTTL3MBTL1AKR1C3
SCHEMBL23671554 0.67 SMN1; SMN2 (0.38) CTSBSMN1; SMN2ALDH1A1MAPK1L3MBTL1
SCHEMBL30683847 0.67 GPR35 (0.45) GPR35SMN1; SMN2ALDH1A1TP53HPGD
SCHEMBL1769433 0.66 TSHR (0.47) ALDH1A1TSHRMAPK1LMNAMAPT
SCHEMBL2388988 0.66 ALDH1A1 (0.66) CTSBSMN1; SMN2ALDH1A1HPGDMAPK1
SCHEMBL23671539 0.66 ALDH1A1 (0.39) CTSBSMN1; SMN2ALDH1A1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11458124-B2 Spirocyclic indane analogues as IL-17 modulators UCBBiopharma Srl (BE) 2022-10-04 — — US disclosed
US-20210228547-A1 Spirocyclic Indane Analogues as IL-17 Modulators UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE) (BE) 2021-07-29 — — US disclosed
CN-112334192-A Spirocyclic indane analogs as IL-17 modulators UCB生物制药有限责任公司 2021-02-05 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210228547-A1 Spirocyclic Indane Analogues as IL-17 Modulators IL17A, IL18, IL23R CTSB 3720/4885GPR35 441/4885SMN1; SMN2 4236/4885
US-11458124-B2 Spirocyclic indane analogues as IL-17 modulators IL17A, IL18, IL23R CTSB 3720/4885GPR35 441/4885SMN1; SMN2 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback